化工社化工社 化学情報印刷レポート · 研究参考用
HCID 12921作成日:2026年11月3日
2-オクチル-1-シクロプロペン-1-オクタン酸
2-オクチル-1-シクロプロペン-1-オクタン酸 · ステルクル酸 · 8-(2-オクチルシクロプロパ-1-エン-1-イル)オクタン酸 · Sterculinic acid · STERCULIC ACID · 9,10-Methylene-9-octadecenoicacid · 2-Octyl-1-cyclopropene-1-octanoic acid · 8-(2-Octacyclopropen-1-yl)octanoic acid
https://huagongshe.com/ja/chemical/12921
識別子と物理属性
| CAS No. | 55088-60-3 |
|---|
| 分子式 | C19H34O2 |
|---|
| 平均分子量 | 294.5 g/mol |
|---|
| 単同位体質量 | 294.25588032 g/mol |
|---|
| SMILES | CCCCCCCCC1=C(CCCCCCCC(=O)O)C1 |
|---|
| InChIKey | PQRKPYLNZGDCFH-UHFFFAOYSA-N |
|---|
| PubChem CID | 12921 |
|---|
| ChEMBL | CHEMBL3677268 |
|---|
| ChEBI | CHEBI:9261 |
|---|
| DTXSID | DTXSID90970445 |
|---|
| 現地名 | 2-オクチル-1-シクロプロペン-1-オクタン酸 |
|---|
化学・物理的性質
| XLogP | 5.8 |
|---|
| 極性表面積 | 37.3 |
|---|
| 水素結合供与体数 | 1 |
|---|
| 水素結合受容体数 | 2 |
|---|
| 回転可能結合数 | 15 |
|---|
| 重原子数 | 21 |
|---|
| 形式電荷 | 0 |
|---|
| 複雑度 | 318 |
|---|
| 物質分類 | Other Classes -> Organic Acids |
|---|
| 脂質 | Fatty Acyls [FA] -> Fatty Acids and Conjugates [FA01] -> Carbocyclic fatty acids [FA0114] |
|---|
| Collision Cross Section | 172.7 Ų [M-H]- [CCS Type: TIMSMethod: single field calibrated] |
|---|
| 融点 | 19 °C |
|---|
| 沸点 | 418.7±24.0 °C(Predicted) |
|---|
| 密度 | 0.948±0.06 g/cm3(Predicted) |
|---|
| 貯蔵条件 | Store at -20°C |
|---|
| 溶解度 | Chloroform: solubleEther: solubleHexane: solubleMethanol: soluble |
|---|
| 外観・状態 | A liquid |
|---|
| pKa(酸解離定数) | 4.78±0.10(Predicted) |
|---|
| 色 | Colorless to light yellow |
|---|
安全性と法規制
| 有害性の概要 | Malvalic and sterculic acid are the primary cyclopropenoid fatty acids (CPRAs) in cottonseed oilThey are synergistic with aflatoxin B1, producing hepatic carcinoma in rainbow trout[HSDB] |
|---|
| Special Reports | THE ROLE OF DIET & NUTRITION IN MODIFYING TUMOR INDUCTION BY CHEMICAL CARCINOGENS IN FOODS & FEEDS IS REVIEWED. FOOD CONTAMINANTS OF MAJOR CONCERN INCLUDE STERCULIC ACID & MALVALIC ACID.[PETERING HGDIET, NUTRITION, AND CANCERADV EXP MED BIOL 91: 207 (1977)] |
|---|
| 相互作用 | AFLATOXIN Q1 (AFQ), A BIOTRANSFORMATION METABOLITE OF AFLATOXIN B1 (AFB), IS FORMED IN VITRO BY HUMAN & MONKEY LIVER MICROSOMES. AFQ WAS FED TO DUPLICATE LOTS OF 80 RAINBOW TROUT FINGERLINGS @ 100 PPB IN A SEMI-PURIFIED TEST DIET FOR 10 MONTHS. ADDNL LOTS WERE FED 100 PPB AFQ PLUS 50 PPM STERCULIC ACID, & 50 PPM CYCLOPROPENE FATTY ACID (CPFA), 4 PPB AFB & THE BASAL TEST DIET TO SERVE AS CONTROLS. HEPATOCELLULAR CARCINOMA INCIDENCES @ 12 MONTHS WERE AS FOLLOWS: 100 PPB AFQ- 12/114 (10.6%)4 PPB AFB- 55/114 (48.2%)50 PPM CPFA- 44/107 (41.1%)100 PPB AFQ PLUS 50 PPM CPFA (STERCULIC ACID)- 106/119 (89.1%) & CONTROL 0/120 (0%). RESULTS ESTABLISH THE CARCINOGENICITY OF AFQ TO RAINBOW TROUT, THE SYNERGISTIC INTERACTION BETWEEN AFQ & CPFA & INDICATE THAT AFQ IS A POTENT LIVER CARCINOGEN ABOUT 100 TIMES LESS CARCINOGENIC THAN AFB.RAINBOW TROUT FED A DIET CONTAINING 20 UG OCHRATOXIN A PER KG OF DIET, TOGETHER WITH STERCULIC ACID, DEVELOPED HEPATOMAS (NUMBER UNSPECIFIED). NO TUMORS WERE OBSERVED WHEN OCHRATOXIN A WAS FED ALONE AT CONCN OF 16, 32, OR 64 UG/KG OF DIET FOR 8 MONTHS.RAINBOW TROUT FED A DIET CONTAINING 200 PPM OF STERCULIC ACID & MALVALIC ACID, SUBSTANCES THAT GREATLY INCR THE SENSITIVITY OF TROUT LIVER CELLS TO CARCINOGENIC EFFECTS OF AFLATOXIN B1. AFTER 4 WK, PECULIAR CLEFT-LIKE STRIATIONS APPEARED IN CYTOPLASM OF HEPATOCYTES. THESE ALTERATIONS BECAME PROGRESSIVELY MORE FREQUENT & MARKED WITH CONTINUED FEEDING OF DIET. AT 8 & 12 WK, ROUGH-SURFACED ENDOPLASMIC RETICULUM CONTAINED MANY PARALLEL ARRAYS & WHORLED PROFILES OF MEMBRANE MATERIAL. GLUCOSE-6-PHOSPHATASE ACTIVITY IN LIVER WAS SIGNIFICANTLY DECREASED.IN MALE WEANLING RATS FED BASAL DIETS OF SATURATED OR UNSATURATED FAT, THE FOLLOWING ADDITIONS WERE MADE: BASAL DIETAFLATOXIN B1 @ 1.7 PPMSTERCULIC ACID @ 210 PPM& AFLATOXIN B1 @ 1.7 PPM, PLUS STERCULIC ACID @ 210 PPM. RATS CONSUMED THESE DIETS FOR 2 MONTHS & THEREAFTER WERE FED UNSUPPLEMENTED BASAL DIET UNTIL SACRIFICE 9 MONTHS LATER. GROWTH WAS DEPRESSED IN ALL RATS GIVEN DIETARY SUPPLEMENTS BUT NO SYNERGISTIC INHIBITION WAS OBSERVED, REGARDLESS OF FAT SOURCE. LIVER WEIGHT DOUBLED IN RESPONSE TO AFLATOXIN |
|---|